Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Novel Variations in Human Interleukin-29 and Their Association

사람의 Interleukin-29 유전자의 새로운 변이의 단리 및 그들의 연관

  • Song, Ju-Hee (Genomic Research Center for Immune Disorders, Wonkwang University School of Medicine) ;
  • Chae, Soo-Cheon (Genomic Research Center for Immune Disorders, Wonkwang University School of Medicine) ;
  • Lee, Jae-Hoon (Department of Otolaryngology, Wonkwang University School of Medicine) ;
  • Chung, Hun-Taeg (Department of Microbiology and Immunology, Wonkwang University School of Medicine)
  • Published : 2004.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Gene polymorphisms of cytokines and their receptors are attractive candidates as genetic factors in the pathogenesis of immune-mediated diseases and have been reported to be associated with disease susceptibility to autoimmune, inflammatory and infectious diseases. IL-29 is one of important candidate genes for complex trait of genetic diseases but there is no published survey of single nucleotide polymorphisms (SNPs) in this gene. In this study, for the first time, we have examined the full genomic sequence of IL-29 including the promoter regions to identify SNPs. We examined the frequencies of genotypes and alleles at the SNP site of IL-29 in allergic rhinitis patients and non-allergic rhinitis controls using the direct sequencing method to determine whether this IL-29 SNP is associated with allergic rhinitis in Korean population. We identified one novel SNP (1184C＞A) in the intron 2 and one novel variation site (-1842_-1841dupGA) in the promoter region of human IL-29 gene. The P values of SNP or variation site were not significant between the healthy controls and allergic rhinitis patients. Our results suggest that the 1184C＞A polymorphism and -1842_-1841dupGA variation site in human IL-29 gene were not associated to allergic rhinitis.

사이토카인과 그들 수용체의 유전자 다형성은 면역작용에 의한 질병들의 발병원인에 있어서 유전적인 인자로 여겨지는 후보물질들로서, 자가면역질환 및 염증성 그리고 감염질환에 민감하게 연관되어 있다고 알려져 있다. 최근 새롭게 보고된 Interleukin-29유전자는 유전학적 질병들의 복잡한 특성을 해결할 수 있는 중요한 후보유전자이지만 이 유전자에 대한 다형성에 대한 연구는 아직 보고된바 없다. 우리는 이 연구에서 처음으로 프로모터부분을 포함한 Interleukin-29 유전자의 전체 지름 DNA에서 유전자의 다형성을 염기서열 분석 방법을 이용하여 탐색하였다. Interleukin-29 유전자의 다형성들이 한국인의 알레르기성 비염의 감염력과 관련되어 있는지를 알아보기 위하여 알레르기성 비염환자 및 알레르기성 비염이 걸리지 않은 정상인의 다형성을 유전자형과 대립유전자의 빈도를 비교분석 하였다. 우리는 이 연구에서 사람의 Interleukin-29 유전자의 한 개의 신규의 다형성 (1184C＞A)을 intron 2에서 그리고 한 개의 신규의 변이부위 (-1842_-1841dupGA)를 프로모터에서 찾아냈다. 우리들의 연구 결과는 이들 유전자 다형성 부위 및 변이부위가 알레르기성 비염과 연관은 없는 것으로 밝혀졌다.

Keywords

References

  1. Eur. J. Immunogenet v.28 A single nucleotide polymorphism at position -109 of the RANTES proximal promoter Azzawi,M.;V.Pravica;P.S.Hasleton;I.V.Hutchinson https://doi.org/10.1046/j.1365-2370.2001.00234.x
  2. J. Allergy Clin. Immunol. v.105 Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors Bellinghausen,I.;U.Brand;J.Knop;J.Saloga https://doi.org/10.1067/mai.2000.105526
  3. Genes Immun. v.1 Cytokine gene polymorphism in human disease: on-line databases Bidwell,J.;L.Keen;G.Gallagher;R.Kimberley;T.Huizinga;M.F.McDermott;J.Oksenberg;J.McNicholl;F.Pociot;C.Hardt;S.D'Alfonso https://doi.org/10.1038/sj.gene.6363649
  4. Adv. Protein Chem. v.52 General mechanisms of cytokine receptor signaling Carpenter,L.R.;G.D.Yancopoulos;N.Stahl https://doi.org/10.1016/S0065-3233(08)60434-9
  5. Allergy v.54 Antigen-presenting cells in nasal allergy Fokkens,W.J. https://doi.org/10.1034/j.1398-9995.1999.00104.x
  6. Genes Immun. v.1 The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma Fryer,A.A.;M.A.Spiteri;A.Bianco;M.Hepple;P.W.Jones;R.C.Strange;R.Makki;G.Tavernier;F.I.Smilie;A.Custovic;A.A.Woodcock;W.E.Ollier;A.H.Hajeer https://doi.org/10.1038/sj.gene.6363717
  7. J. Immunol. v.166 Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus Gibson,A.W.;J.C.Edberg;J.Wu;R.G.Westendorp;T.W.Huizinga;R.P.Kimberly https://doi.org/10.4049/jimmunol.166.6.3915
  8. Genes Immun. v.1 Genetic polymorphism of IL-12 p40 gene in immunemediated disease Hall,M.A.;E.McGlinn;G.Coakley;S.A.Fisher;K.Boki;D.Middleton;E.Kaklamani;H.Moutsopoulos;T.P.Jr.Loughran;W.E.Ollier;G.S.Panayi;J.S.Lanchbury https://doi.org/10.1038/sj.gene.6363661
  9. Int. Rev. of Immunol. v.17 Signal transduction through cytokine receptors Hibi,M.;T.Hirano https://doi.org/10.3109/08830189809084488
  10. BMJ v.316 Disease pathogenic mechanisms in allergy: a rational basis for treatment Howarth,P.H.
  11. J. Hum. Genet. v.46 Five novel single-nucleotide polymorphisms of human interferon gamma identified by sequencing the entire gene Iwasaki,H.;N.Ota;T.Nakajima;Y.Shinohara;M.Kodaira;M.Kajita;M.Emi https://doi.org/10.1007/s100380170121
  12. Nature Immunol. v.4 IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex Kotenko,S.V.;G.Gallagher;V.V.Baurin;A.Lewis-Antes;M.Shen;N.K.Shah;J.A.LangerF.Sheikh;H.Dickensheets;R.P.Donnelly https://doi.org/10.1038/ni875
  13. J. Allergy Clin. Immunol v.107 Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma Nakao,F.;K.Ihara;K.Kusuhara;Y.Sasaki;N.Kinukawa;A.Takabayashi;S.Nishima;T.Hara https://doi.org/10.1067/mai.2001.113051
  14. Int. Rev. of Immunol v.16 Cytokine receptors: structures and signal transduction Onishi,M.;T.Nosaka;T.Kitamura https://doi.org/10.3109/08830189809043011
  15. Cell v.109 Cytokine signaling in 2002: new surprises in the Jak/Stat pathway O'Shea,J.J.;M.Gadina;R.D.Schreiber https://doi.org/10.1016/S0092-8674(02)00701-8
  16. J. Allergy Clin. Immunol v.105 The role of lymphocytes in allergic disease Romagnani,S. https://doi.org/10.1067/mai.2000.104575
  17. Cytokine and Growth Factor Rev. v.9 Recent advances in cytokines, cytokine receptors and signal transduction Rubinstein,M.;C.A.Dinarello;J.J.Oppenheim;P.Hertzog https://doi.org/10.1016/S1359-6101(98)00006-9
  18. Nature Immunol v.4 IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R Sheppard,P.;W.Kindsvogel;W.Xu;K.Henderson;S.Schlutsmeyer;T.E.Whitmore;R.Kuestner;U.Garrigues;C.Birks;J.Roraback;C.Ostrander;D.Dong;J.Shin;S.Presnell;B.Fox;B.Haldeman;E.Cooper;D.Taft;T.Gibert;F.J.Grant;M.Tackett;W.Krivan;G.McKnight;C.Clegg;D.Foster;K.M.Klucher https://doi.org/10.1038/ni873